(2E)-N-[(3,4-Dichlorophenyl)methyl]-3-[4-(3-fluoropropoxy)phenyl]prop-2-enamide

Catalog No. :
ACISYV386
CAS No. :
1164561-95-8
Molecular Formula :
C19H18Cl2FNO2
Molecular Weight :
382.26

IUPAC Name:(E)-N-(3,4-dichlorobenzyl)-3-(4-(3-fluoropropoxy)phenyl)acrylamide

(2E)-N-[(3,4-Dichlorophenyl)methyl]-3-[4-(3-fluoropropoxy)phenyl]prop-2-enamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$511.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2E)-N-[(3,4-Dichlorophenyl)methyl]-3-[4-(3-fluoropropoxy)phenyl]prop-2-enamide
IUPAC Name(E)-N-(3,4-dichlorobenzyl)-3-(4-(3-fluoropropoxy)phenyl)acrylamide
MDL No.MFCD02102408
Molecular FormulaC19H18Cl2FNO2
Molecular Weight382.26
SMILESO=C(NCC1=CC=C(Cl)C(Cl)=C1)/C=C/C2=CC=C(OCCCF)C=C2
InChI KeyWDNKTQFPWGJRGF-WEVVVXLNSA-N
Synonym(E)-N-(3,4-DICHLOROBENZYL)-3-[4-(3-FLUOROPROPOXY)PHENYL]-2-PROPENAMIDE;2-Propenamide, N-[(3,4-dichlorophenyl)methyl]-3-[4-(3-fluoropropoxy)phenyl]-, (2E)-;(E)-N-(3,4-dichlorobenzyl)-3-(4-(3-fluoropropoxy)phenyl)acrylamide
CAS No.1164561-95-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACISYV386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACISYV386 route product structure diagram
    ACISYV3861164561-95-8
Inquiry

2. ACISYV386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACISYV386 route product structure diagram
    ACISYV3861164561-95-8
Inquiry

Comments (0)